MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

10 Hot Devices We Can't Get in the U.S.—Thoratec's HeartMate PHP

10 Hot Devices We Can't Get in the U.S.—Thoratec's HeartMate PHP
 

Thoratec's HeartMate PHP

Thoratec's HeartMate PHP is a heart pump intended for hemodynamic support in high-risk percutaneous coronary intervention (PCI) patients. HeartMate PHP received CE Mark in July 2015 but does not yet have FDA approval.

The SHIELD II U.S. pivotal trial is to be conducted in patients undergoing high-risk PCI to support an FDA approval. The randomized trial pits HeartMate PHP against Abiomed's Impella 2.5, which has FDA approval and is the only direct competitor.

Analysts expect HeartMate PHP could receive FDA approval in 2018. 

             

[Image courtesy of THORATEC CORP.]  

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish